This article reviews the regulatory mechanisms of BBR in CRC development, which may exert its effects through delaying Fn (Stage 1), reversing Fn-induced intestinal adenoma-carcinoma transition (Stage 2), and remedying Fn-associated CRC (Stage 3). The gene discussed is FN1; the disease is carcinoma.